Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)

Clinical trial NCT00903721 · COMPLETED

Trial details

NCT number: NCT00903721
Sponsor: Organon and Co
Status: COMPLETED
Study type: OBSERVATIONAL

Allergic Rhinitis

Start date: 2008-11-01
Primary completion: 2012-10-01
Enrollment: 3806

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.